Method for preparing (2s)-6-fluoro-3,4-dihydro-4-oxy-2H-1-benzopyranyl-2-carboxylic acid
A benzopyran and dihydro technology is applied in the field of preparing the key intermediate of oral aldose reductase inhibitor fidarestat, which can solve the problem that the target product of optical configuration cannot be obtained, the difficulty of product separation and purification is increased, and the separation The effect is not obvious, and the process parameters are easier to control, difficult to buy, and the price is low.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0036] Lipase adopts lipase NOVO 435, product of Danish NOVO company.
[0037] Add 5.0g of compound (±)-6-fluoro-3,4-dihydro-4-oxo-2H-1-benzopyran-2-carboxylic acid, 150ml of methanol, and add 0.1% sulfuric acid with a weight concentration of 98%. ml, reflux for 4 hours, concentrate under reduced pressure, and recrystallize from methanol to obtain 5.1 g of compound II as a solid;
[0038] Take 1.0 g of the above solid, 0.1 g of lipase, 9.5 ml of acetonitrile, and 0.5 ml of water, and react for 12 hours at 37° C. with a pH value of 7.0. After the reaction is completed, filter out the lipase, and add 15 ml of 2.5% NaHCO by weight to the filtrate. 3 solution, stirred in an ice bath for 3h, filtered;
[0039] The filtrate was adjusted to pH = 1 with 32% hydrochloric acid by weight to obtain solid (2S)-6-fluoro-3,4-dihydro-4-oxo-2H-1-benzopyran-2-carboxylic acid 0.37 g.
[0040] The above-mentioned solid is detected by high performance liquid phase, detection condition: use chir...
Embodiment 2
[0044] Using lipase RMIM, the product of Japan Nuoyou Enzyme Preparation Co., Ltd.;
[0045] Compound (±)-6-fluoro-3,4-dihydro-4-oxo-2H-1-benzopyran-2-carboxylic acid 5.0g, ethanol 150ml, pass through dry HCL gas for 30 minutes, reflux reaction 4h, concentrated under reduced pressure, and recrystallized with methanol to obtain 5.4g of solid. Take 1.0g of the above solid, 0.03g of lipase, 9.7ml of acetonitrile, and 0.3ml of water. React for 6h at 30°C with a pH value of 6.0, and filter after the reaction is complete. Remove lipase, add 15ml weight concentration and be 2.5%Na in the filtrate 2 CO 3 Solution, stirred in ice bath for 4h, filtered: the filtrate was adjusted to pH=1 with concentrated hydrochloric acid to obtain solid (2S)-6-fluoro-3,4-dihydro-4-oxo-2H-1-benzopyran-2 - Carboxylic acid 0.20 g. The above-mentioned solid is detected by high performance liquid phase, detection condition: use chiral column AD-H, mobile phase is n-hexane:isopropanol=87%:13%.
[0046] M...
Embodiment 3
[0048] Lipase adopts lipase NOVO 435, product of Danish NOVO company.
[0049] Compound (±)-6-fluoro-3,4-dihydro-4-oxo-2H-1-benzopyran-2-carboxylic acid 5.0g, n-propanol 150ml, flow into dry HCL gas for 30 minutes, Reflux for 6 hours, concentrate under reduced pressure, and recrystallize with methanol to obtain 5.8 g of solid. Take 1.0 g of the above solid, 0.04 g of lipase, 9.5 ml of acetonitrile, and 0.5 ml of water. Filter to remove lipase, add 15ml 2.5% KHCO to the filtrate 3 Solution, stirred in ice bath for 4h, filtered: the filtrate was adjusted to pH=1 with concentrated hydrochloric acid to obtain solid (2S)-6-fluoro-3,4-dihydro-4-oxo-2H-1-benzopyran-2 - Carboxylic acid 0.28 g. The above-mentioned solid is detected by high performance liquid phase, detection condition: use chiral column AD-H, mobile phase is n-hexane:isopropanol=87%:13%.
[0050] Melting point, mp 174-176°C; Optical rotation: [α] D 20 +56°(c 1.0, MeOH) NMR 1 H-NMR (DMSO-d): δ: 3.1 (d, 2H), 5.2 (t...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


